Revive Therapeutics Ltd. Logo

Revive Therapeutics Ltd. (RVV)

CSE

Currency in CAD
0.0250
0.00 (0.00%)

Closed

Aug 24, 2026

Day's Range

0.0250
0.0250

52 wk Range

0.00500
0.0800

Overview - RVV - Revive Therapeutics Ltd.

Key Statistics

Valuation

Enterprise Value

10.95M

P/E (Trailing)

‪-0.83‬

Price / Book

‪-2.70‬

EV / EBITDA

‪-8.40‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪0.00%‬

Return on Assets

‪-16.44%‬

Return on Equity

‪-1,108.41%‬

Ownership

Shares Outstanding

435.67M

Float

429.35M

Held by Insiders

‪1.51%‬

Held by Institutions

‪0.0020%‬

Price stats

Beta

‪-1.85‬

50-Day Avg

‪0.0287‬

200-Day Avg

‪0.0247‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - RVV - Revive Therapeutics Ltd.

Peers - RVV - Revive Therapeutics Ltd.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on CSE.

Profile Summary - RVV - Revive Therapeutics Ltd.

About

Revive Therapeutics Ltd. is a life sciences company engaged in the research and development of novel therapies and technologies aimed at addressing unmet medical needs. The company primarily focuses on rare disorders and infectious diseases, undertaking initiatives to develop and improve existing treatments through…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.